99 related articles for article (PubMed ID: 16675903)
1. Potential new antimalarial chemotherapeutics based on sphingolipid metabolism.
Pankova-Kholmyansky I; Flescher E
Chemotherapy; 2006; 52(4):205-9. PubMed ID: 16675903
[TBL] [Abstract][Full Text] [Related]
2. Anti-Plasmodium activity of ceramide analogs.
Labaied M; Dagan A; Dellinger M; Gèze M; Egée S; Thomas SL; Wang C; Gatt S; Grellier P
Malar J; 2004 Dec; 3():49. PubMed ID: 15588325
[TBL] [Abstract][Full Text] [Related]
3. Ceramide mediates growth inhibition of the Plasmodium falciparum parasite.
Pankova-Kholmyansky I; Dagan A; Gold D; Zaslavsky Z; Skutelsky E; Gatt S; Flescher E
Cell Mol Life Sci; 2003 Mar; 60(3):577-87. PubMed ID: 12737317
[TBL] [Abstract][Full Text] [Related]
4. Helicases - feasible antimalarial drug target for Plasmodium falciparum.
Tuteja R
FEBS J; 2007 Sep; 274(18):4699-704. PubMed ID: 17824956
[TBL] [Abstract][Full Text] [Related]
5. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
[TBL] [Abstract][Full Text] [Related]
6. Plasmodium falciparum: new molecular targets with potential for antimalarial drug development.
Gardiner DL; Skinner-Adams TS; Brown CL; Andrews KT; Stack CM; McCarthy JS; Dalton JP; Trenholme KR
Expert Rev Anti Infect Ther; 2009 Nov; 7(9):1087-98. PubMed ID: 19883329
[TBL] [Abstract][Full Text] [Related]
7. The past, present and future of antifolates in the treatment of Plasmodium falciparum infection.
Nzila A
J Antimicrob Chemother; 2006 Jun; 57(6):1043-54. PubMed ID: 16617066
[TBL] [Abstract][Full Text] [Related]
8. Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update.
Kumar S; Guha M; Choubey V; Maity P; Bandyopadhyay U
Life Sci; 2007 Feb; 80(9):813-28. PubMed ID: 17157328
[TBL] [Abstract][Full Text] [Related]
9. [Transport proteins as drug targets in Plasmodium falciparum. New perspectives in the treatment of malaria].
Ellekvist P; Colding H
Ugeskr Laeger; 2006 Mar; 168(13):1314-7. PubMed ID: 16579884
[TBL] [Abstract][Full Text] [Related]
10. Plasmodium kinases as targets for new-generation antimalarials.
Lucet IS; Tobin A; Drewry D; Wilks AF; Doerig C
Future Med Chem; 2012 Dec; 4(18):2295-310. PubMed ID: 23234552
[TBL] [Abstract][Full Text] [Related]
11. [Current antimalarial drugs: resistance and new strategies].
Ringwald P
Bull Acad Natl Med; 2007 Oct; 191(7):1273-84; discussion 1284. PubMed ID: 18447049
[TBL] [Abstract][Full Text] [Related]
12. Proteases of malaria parasites: new targets for chemotherapy.
Rosenthal PJ
Emerg Infect Dis; 1998; 4(1):49-57. PubMed ID: 9452398
[TBL] [Abstract][Full Text] [Related]
13. Strategies to reverse drug resistance in malaria.
Egan TJ; Kaschula CH
Curr Opin Infect Dis; 2007 Dec; 20(6):598-604. PubMed ID: 17975410
[TBL] [Abstract][Full Text] [Related]
14. Plasmodium falciparum gametocyte sex ratios in symptomatic children treated with antimalarial drugs.
Sowunmi A; Balogun ST; Gbotosho GO; Happi CT
Acta Trop; 2009 Feb; 109(2):108-17. PubMed ID: 19027703
[TBL] [Abstract][Full Text] [Related]
15. Antimalarial drug therapy: the role of parasite biology and drug resistance.
Daily JP
J Clin Pharmacol; 2006 Dec; 46(12):1487-97. PubMed ID: 17101748
[TBL] [Abstract][Full Text] [Related]
16. New uses for old drugs. Auranofin, a clinically established antiarthritic metallodrug, exhibits potent antimalarial effects in vitro: Mechanistic and pharmacological implications.
Sannella AR; Casini A; Gabbiani C; Messori L; Bilia AR; Vincieri FF; Majori G; Severini C
FEBS Lett; 2008 Mar; 582(6):844-7. PubMed ID: 18294965
[TBL] [Abstract][Full Text] [Related]
17. Mefloquine--its 20 years in the Thai Malaria Control Program.
Wongsrichanalai C; Prajakwong S; Meshnick SR; Shanks GD; Thimasarn K
Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):300-8. PubMed ID: 15691128
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of the in vitro sensitivity of Plasmodium falciparum to artemisinin in two border areas of Thailand.
Woitsch B; Wernsdorfer G; Prajakwong S; Rojanawatsirivet C; Kollaritsch H; Wernsdorfer WH
Wien Klin Wochenschr; 2004; 116 Suppl 4():35-40. PubMed ID: 15683041
[TBL] [Abstract][Full Text] [Related]
19. An analytical presentation of drug resistance in Plasmodium falciparum and guidelines to formulate a drug strategy.
Pandya AP; Sharma RS; Sahu GC
J Commun Dis; 1995 Mar; 27(1):44-54. PubMed ID: 7636152
[TBL] [Abstract][Full Text] [Related]
20. [Mefloquine resistance in Plasmodium falciparum malaria].
Garavelli PL
Recenti Prog Med; 2003; 94(7-8):343. PubMed ID: 12868243
[No Abstract] [Full Text] [Related]
[Next] [New Search]
